Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll The impact of early cytomegalovirus infection and disease in renal transplant recipients Sagedal S; Hartmann A; Rollag HClin Microbiol Infect 2005[Jul]; 11 (7): 518-30Human cytomegalovirus (HCMV) infection is the single most frequent infectious complication in the early period after kidney transplantation. The HCMV load in blood, measured by HCMV PCR or the HCMV pp65 antigen test, is a predictor of HCMV disease in seropositive recipients. However, plasma virus load measurements are of only modest value in predicting the risk of HCMV disease in seronegative recipients of kidneys from seropositive donors. HCMV infection is an independent risk-factor for acute kidney graft rejection. There is also evidence that HCMV is associated with an increased long-term mortality and post-transplant diabetes mellitus. Whether pre-emptive or prophylactic therapy should be the preferred strategy is not yet decided. Some studies indicate that HCMV prophylaxis may reduce the risk of acute rejection, and thereby increase long-term graft survival in seronegative recipients of kidneys from seropositive donors.|*Cytomegalovirus Infections/diagnosis/prevention & control/virology[MESH]|*Kidney Transplantation[MESH]|*Postoperative Complications[MESH]|Antiviral Agents/therapeutic use[MESH]|Cytomegalovirus/physiology[MESH]|Graft Rejection/prevention & control[MESH]|Graft Survival[MESH]|Humans[MESH]|Phosphoproteins/blood[MESH]|Predictive Value of Tests[MESH]|Risk Factors[MESH]|Viral Load[MESH]|Viral Matrix Proteins/blood[MESH]|Viremia[MESH] |